Detalhe da pesquisa
1.
Ca2+ imaging of self and other in medial prefrontal cortex during social dominance interactions in a tube test.
Proc Natl Acad Sci U S A
; 119(31): e2107942119, 2022 08 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35881809
2.
Identification of BiP as a CB1 Receptor-Interacting Protein That Fine-Tunes Cannabinoid Signaling in the Mouse Brain.
J Neurosci
; 41(38): 7924-7941, 2021 09 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-34353897
3.
ß-Adrenergic Receptors/Epac Signaling Increases the Size of the Readily Releasable Pool of Synaptic Vesicles Required for Parallel Fiber LTP.
J Neurosci
; 40(45): 8604-8617, 2020 11 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33046543
4.
The loss of ß adrenergic receptor mediated release potentiation in a mouse model of fragile X syndrome.
Neurobiol Dis
; 130: 104482, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31129085
5.
The activation of mGluR4 rescues parallel fiber synaptic transmission and LTP, motor learning and social behavior in a mouse model of Fragile X Syndrome.
Mol Autism
; 14(1): 14, 2023 04 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37029391
6.
Control of a hippocampal recurrent excitatory circuit by cannabinoid receptor-interacting protein Gap43.
Nat Commun
; 14(1): 2303, 2023 04 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-37085487
7.
Neuroprotection by Phytoestrogens in the Model of Deprivation and Resupply of Oxygen and Glucose In Vitro: The Contribution of Autophagy and Related Signaling Mechanisms.
Antioxidants (Basel)
; 9(6)2020 Jun 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-32580379
8.
Avarol derivatives as competitive AChE inhibitors, non hepatotoxic and neuroprotective agents for Alzheimer's disease.
Eur J Med Chem
; 122: 326-338, 2016 Oct 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-27376495
9.
Potent anticholinesterasic and neuroprotective pyranotacrines as inhibitors of beta-amyloid aggregation, oxidative stress and tau-phosphorylation for Alzheimer's disease.
Eur J Med Chem
; 118: 178-92, 2016 Aug 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-27128182
10.
Pyranopyrazolotacrines as nonneurotoxic, Aß-anti-aggregating and neuroprotective agents for Alzheimer's disease.
Future Med Chem
; 7(7): 845-55, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26061104
11.
Toxicological and pharmacological evaluation, antioxidant, ADMET and molecular modeling of selected racemic chromenotacrines {11-amino-12-aryl-8,9,10,12-tetrahydro-7H-chromeno[2,3-b]quinolin-3-ols} for the potential prevention and treatment of Alzheimer's disease.
Eur J Med Chem
; 74: 491-501, 2014 Mar 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-24502897